1. Resources

Mouse Genetics and Gene Targeting CoRE

The Mouse Genetics and Gene Targeting CoRE at the Icahn School of Medicine at Mount Sinai provides mouse model creation and related services for Mount Sinai investigators and external customers.

Our facility is equipped with cutting-edge technology and highly trained staff to offer full model creation services, from consultation until delivery of germline-confirmed genetically engineered mouse models (GEMMs). To this purpose, we employ the latest genome editing tools such as CRISPR/Cas9 and the assisted reproductive technology to rapidly generate GEMMs with diverse genome modifications. In addition, we continue to support model creation via the traditional transgenesis and the gene targeting in the embryonic stem cells. Animals produced in the CoRE are thoroughly genotyped through our comprehensive genotyping services to ensure timely delivery of corrected edited animals. By providing these essential tools, we support the advancement of biomedical research and the development of novel therapeutic strategies.

In addition to the creation of novel GEMMs, the CoRE can assist laboratories with the maintenance of existing lines through the cryopreservation of sperm. Cryopreservation of mouse sperm allows investigators to successfully bank lines that are not in active use. Shipment of cryopreserved sperm can also serve as an alternative method for transferring lines to collaborators at other institutions.

In collaboration with the Center for Comparative Medicine and Surgery, the CoRE also provides investigators with the means to import novel lines from other institutions by recovering mice from cryopreserved embryos or sperm, live embryos, or using IVF rederivation of individual males that are shipped to the Icahn School of Medicine at Mount Sinai. This service is an excellent alternative to the importation of rodents via live animal quarantine.

Acknowledgement of the Mouse Genetics and Gene Targeting CoRE in all publications that include any data derived from this facility help to support the CoRE.

Meet Our Team

Youngwook Ahn, PhD
Youngwook Ahn, PhD
SENIOR FACULTY | Cell, Developmental & Regenerative Biology
PEDRO SANABRIA
PEDRO SANABRIA
CORE OPERATIONS MANAGER-MSH | Shared Research Facilities
NIKA HINES
NIKA HINES
ASSOCIATE RESEARCHER I | Shared Research Facilities

Our Services

This approach allows the CoRE to rapidly generate GEMMs with diverse genome modifications such as humanization, large insertion, conditional knockout, base substitution, and deletion. The CoRE designs CRISPR guides and repair donors (oligonucleotide, long single-stranded DNA, double-stranded DNA or rAAV), which are synthesized in-house or procured through external vendors. Potential founder (F0) mice are produced by delivering the editing reagents into zygotes with electroporation or microinjection. F0 mice are thoroughly genotyped via our comprehensive genotyping service, and selected F0 mice are bred with wild-type mice for germline transmission. The CoRE offers N1 breeding service and confirmed heterozygous mice are transferred to investigators.

We offer microinjection of purified DNA constructs for the production of transgenic mice. Investigators provide midi- or maxi-prep DNA digested with appropriate restriction enzyme(s), and the CoRE gel-purifies a desired DNA fragment suitable for microinjection. A minimum of two transgenics or 30 live births or embryos, whichever comes first, is prepared for each set of injections charged to an investigator.

The CoRE provides microinjection of an embryonic stem (ES) cell clone into mouse blastocysts to establish chimeric mice to produce knockout mouse lines. Investigators provide targeted ES cells suitable for chimera production on the day of blastocyst injection.

The long-term storage of mouse sperm and/or embryos reduces the need for constant maintenance of lines not essential for current research needs, as well as providing a backup repository of important lines in case of environmental or weather-related crises. To minimize losses in the case of a freezer failure, cryopreserved sperm samples are maintained in two separate locations.

Cryopreserved sperm samples can be shipped from Mount Sinai to collaborators around the world. This service includes the preparation and loading of dry liquid nitrogen shippers with frozen sperm samples.

The CoRE recovers lines from which sperm have been frozen and stored at the Icahn School of Medicine at Mount Sinai.

Mouse lines can be imported into the Icahn School of Medicine at Mount Sinai by obtaining one to two males from a collaborator at another institution. These males are used to prepare sperm for <em>in vitro</em> fertilization of wild-type mouse oocytes. Alternatively, frozen sperm can be imported instead of live animals and used for <em>in vitro</em> fertilization. The fertilized embryos are transferred to specific pathogen-free hosts to generate clean mice. The CoRE also works with investigators to import lines of mice into Mount Sinai through frozen early-stage embryos. In addition, in-house mouse lines infected with various mouse pathogens may be cleaned by transferring embryos to pathogen-free hosts.

The CoRE can develop a PCR-based assay based on absence-presence of an amplicon and/or Sanger sequencing to genotype mouse tissues. The CoRE extracts genomic DNA, runs PCR/agarose gel and, if requested, purifies and sequences the PCR product.

The CoRE can provide mouse embryos at various preimplantation stages. In addition, the CoRE can perform timed matings with new lines created in-house to produce embryos for rapid characterization.

Investigators provide 6-10 homozygous male mice to be mated with superovulated wild-type females. Heterozygous embryos are collected and transferred to surrogate females. Resulting female progeny are superovulated and bred to the same homozygous males. Embryos are collected and transferred to surrogate females, leading to production of a large number of homozygous and heterozygous mice. Other strategies, such as IVF, may be utilized to suit the investigator's needs.

Frequently Asked Questions

We recommend that investigators consult with the CoRE director before submitting a request for a new model creation in iLab. After consultation, the CoRE provides a project plan for review and initiates the project once the plan is approved by investigators. For the genome editing with CRISPR, the timeline is determined by several factors, such as the nature of desired genome modifications, type of repair donors, and strain background, but it typically takes approximately two and a half to four months to identification of founder (F0) animals carrying a desired editing event. For conventional transgenic models and chimera production, it typically takes approximately two months to have F0 animals ready for genotyping.

Yes, we recommend that founders (F0) are bred and genotyped for germline transmission in our facility. F0 animals from CRISPR editing are considered mosaic, consisting of multiple populations of cells each with different editing events (desired and undesired alleles), and hence need to be bred with wild-type animals. After the N1 breeding, each mouse should be heterozygous for a particular allele. Genotyping of CRISPR-edited animals should be performed thoroughly to verify correct editing across the whole edited region while minimizing the risk of off-target editing.

No, the facility does not cryopreserve mouse embryos. Cryopreserving embryos is more complicated, as it usually requires female mice of a certain age (five to six weeks old) to be super ovulated and mated with males of the same line that are 3 to 10 months of age. For each attempt at embryo cryopreservation, at least 10 to 12 females (and an equal number of males for the mating) are required, and this is usually difficult to organize with the requesting lab.

The CoRE facility has successfully used males greater than 24 months of age to rescue mouse lines by IVF. This is not ideal, however, since males tend to have reduced or no sperm counts as they age, which make IVF recovery less likely with age.